122 related articles for article (PubMed ID: 21177674)
1. Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.
Souli M; Konstantinidou E; Tzepi I; Tsaganos T; Pefanis A; Chryssouli Z; Galani I; Giamarellos-Bourboulis E; Giamarellou H
J Antimicrob Chemother; 2011 Mar; 66(3):611-7. PubMed ID: 21177674
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Lee NY; Huang WH; Tsui KC; Hsueh PR; Ko WC
Diagn Microbiol Infect Dis; 2011 May; 70(1):150-3. PubMed ID: 21398070
[TBL] [Abstract][Full Text] [Related]
3. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
[No Abstract] [Full Text] [Related]
4. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
Devrim I; Gulfidan G; Gunay I; Agın H; Güven B; Yılmazer MM; Dizdarer C
Expert Opin Pharmacother; 2011 Apr; 12(6):845-9. PubMed ID: 21323503
[TBL] [Abstract][Full Text] [Related]
8. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
[TBL] [Abstract][Full Text] [Related]
9. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
[TBL] [Abstract][Full Text] [Related]
10. Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Lee CH; Su LH; Lin WC; Tang YF; Liu JW
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e183-6. PubMed ID: 19800278
[TBL] [Abstract][Full Text] [Related]
11. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
Behera B; Mathur P; Das A; Kapil A
Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community.
Vitti D; Protonotariou E; Sofianou D
Int J Antimicrob Agents; 2009 Aug; 34(2):187-8. PubMed ID: 19324525
[No Abstract] [Full Text] [Related]
13. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
14. Emergence of VIM-1 metallo-β-lactamase-producing Escherichia coli in a neonatal intensive care unit.
Papadimitriou M; Voulgari E; Ranellou K; Koemtzidou E; Lebessi E; Tsakris A
Microb Drug Resist; 2011 Mar; 17(1):105-8. PubMed ID: 21117968
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
[TBL] [Abstract][Full Text] [Related]
16. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
17. Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
Gandra S; Choi J; McElvania E; Green SJ; Harazin M; Thomson RB; Dantas G; Singh KS; Das S
Int J Antimicrob Agents; 2020 Mar; 55(3):105902. PubMed ID: 31954833
[TBL] [Abstract][Full Text] [Related]
18. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.
Colodner R; Samra Z; Keller N; Sprecher H; Block C; Peled N; Lazarovitch T; Bardenstein R; Schwartz-Harari O; Carmeli Y;
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):201-5. PubMed ID: 17258084
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
